Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Esserman

Showing results (11-20 of 143) with videos related to

Pageof 15
Sort By:
JAMA Oncology|August 21, 2015
Rethinking the Standard for Ductal Carcinoma In Situ TreatmentLaura Esserman, Christina Yau
Journal of the National Cancer Institute|April 24, 2010
Solving the overdiagnosis dilemmaLaura Esserman, Ian Thompson
Annals of Surgical Oncology|March 16, 2004
Neoadjuvant hormonal therapy for ductal carcinoma in situ: trial design and preliminary resultsE Shelley Hwang, Laura Esserman
Journal of Women'S Health (2002)|July 29, 2014
Moving beyond the breast cancer screening debateLaura Esserman, Margaret E O'Kane
The New England Journal of Medicine|December 7, 2017
Mechanisms of Resistance to Neoadjuvant Chemotherapy in Breast CancerAngela DeMichele, Douglas Yee, Laura Esserman
BMJ (Clinical Research Ed.)|February 3, 2016
Detection of ductal carcinoma in situ and subsequent interval cancersYiwey Shieh, Martin Eklund, Laura Esserman
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Targeting Molecular Aberrations in Breast Cancer: Is It about Time?Laura Esserman, Christopher Benz, Angela Demichele
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Overdiagnosis and overtreatment of breast cancerMichael Alvarado, Elissa Ozanne, Laura Esserman
JAMA|October 22, 2009
Rethinking screening for breast cancer and prostate cancerLaura Esserman, Yiwey Shieh, Ian Thompson
European Journal of Cancer (Oxford, England : 1990)|November 4, 2008
Converting evidence to practice: a guide for the clinical application of MRI for the screening and management of breast cancerJennifer Zakhireh, Rachel Gomez, Laura Esserman
Pageof 15

Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
JAMA Oncology|August 21, 2015
Rethinking the Standard for Ductal Carcinoma In Situ TreatmentLaura Esserman, Christina Yau
Journal of the National Cancer Institute|April 24, 2010
Solving the overdiagnosis dilemmaLaura Esserman, Ian Thompson
Annals of Surgical Oncology|March 16, 2004
Neoadjuvant hormonal therapy for ductal carcinoma in situ: trial design and preliminary resultsE Shelley Hwang, Laura Esserman
Journal of Women'S Health (2002)|July 29, 2014
Moving beyond the breast cancer screening debateLaura Esserman, Margaret E O'Kane
The New England Journal of Medicine|December 7, 2017
Mechanisms of Resistance to Neoadjuvant Chemotherapy in Breast CancerAngela DeMichele, Douglas Yee, Laura Esserman
BMJ (Clinical Research Ed.)|February 3, 2016
Detection of ductal carcinoma in situ and subsequent interval cancersYiwey Shieh, Martin Eklund, Laura Esserman
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Targeting Molecular Aberrations in Breast Cancer: Is It about Time?Laura Esserman, Christopher Benz, Angela Demichele
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Overdiagnosis and overtreatment of breast cancerMichael Alvarado, Elissa Ozanne, Laura Esserman
JAMA|October 22, 2009
Rethinking screening for breast cancer and prostate cancerLaura Esserman, Yiwey Shieh, Ian Thompson
European Journal of Cancer (Oxford, England : 1990)|November 4, 2008
Converting evidence to practice: a guide for the clinical application of MRI for the screening and management of breast cancerJennifer Zakhireh, Rachel Gomez, Laura Esserman
Pageof 15